News | September 04, 2008

Digirad Developing New Cardiac SPECT Imaging System With Distortion Correction

September 5, 2008 - Digirad Corp. today announced the initial clinical trial of its new SPECT imaging system incorporating new proprietary technology to correct attenuation, an inherent issue in cardiac SPECT imaging.

The new system, Cardius X-ACT, will be exhibited at the 2008 Annual Scientific Session of the American Society of Nuclear Cardiology (ASNC) Sept. 10-14, 2008, at the John B. Hynes Convention Center in Boston.

Cardiac SPECT (single photon emission computed tomography) used for myocardial perfusion imaging is a noninvasive test to assess the heart’s structure and function. Small amounts of radioactive substances are injected into the patient’s vein, and gamma cameras produce images of the blood flow in the heart. These SPECT images are used to identify blockages in coronary arteries, determine whether a patient has had a heart attack, evaluate risk of a heart attack, and assess a patient’s condition after bypass surgery or angioplasty.

However, attenuation can cause misdiagnosis of the images, which is one of the most significant issues in cardiac SPECT. There are alternative solutions that attempt to address this problem, but Digirad said they involve tradeoffs, such as noisy images, truncated scans, lengthy procedures with risk of excess movement by patients, or higher levels of radiation dosage.

Research based using the company’s Cardius 3 triple-head SPECT camera, and feedback from initial clinical trials of the Cardius X-ACT at the University of California, Los Angeles (UCLA) is promising, compared to other SPECT systems at competitive price points, Digirad said. The company said the new device shows improvement in imaging clarity and accuracy, more rapid imaging, and a significant reduction in radiation dosage.

Two other clinical studies are planned for the Cardius X-ACT system, which is expected to be available for sale sometime in mid-2009 pending FDA approval.

For more information: www.digirad.com

Related Content

PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
Nuclear imaging scan showing very good tissue delineation. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Nuclear imaging scan showing very good tissue delineation. It offers crisp overall image quality and sharply delineates the muscle and fat planes, vertebral margins and end plates, billiary radicals, renal calyces, aortic wall and papillary muscles of the heart. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S.
Emerging Trends in Nuclear Medicine
Feature | Nuclear Imaging | June 04, 2018 | By Jeff Zagoudis
Nuclear imaging and its various modalities have long played an important role in the diagnosis and treatment of numer
News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
PET Imaging Agent Could Provide Early Diagnosis of Rheumatoid Arthritis

Coronal 18F-FEDAC PET/CT section of a mouse with collagen-induced arthritis. (A) On day 23 and day 37, increased uptake is noted in the front and hind paws of this mouse with collagen-induced arthritis. (B) Predictive performance of day 23 18F-FEDAC uptake for the development of clinical arthritis. ROC = receiver operating characteristic; Sn = sensitivity; Sp = specificity. Credit: Seoul National University and Ewha Womans University, Seoul, South Korea

News | PET Imaging | May 17, 2018
A novel positron emission tomography (PET) tracer developed by Korean researchers can visualize joint inflammation and...
PET Imaging Shows Protein Clumping May Contribute to Heart Failure Development
News | PET Imaging | May 11, 2018
A team led by Johns Hopkins University Researchers has discovered that protein clumps appear to accumulate in the...
News | Radiopharmaceuticals and Tracers | May 09, 2018
Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a specialist in...
Cardiac MRI being performed at the DeBakey Heart Hospital.

Cardiac MRI being performed at the DeBakey Heart Hospital.

Feature | Cardiac Imaging | May 03, 2018 | By Jeff Zagoudis
Magnetic resonance imaging (MRI) for cardiac assessment provides a radiation-free alternative to other commonly used...
Novel PET Agent Could Help Guide Therapy for Brain Diseases

Rat brain 11C‐Me‐NB1 PET images (0‐60 min) superimposed on an MRI template. Credit: SD Krämer et al., ETH Zurich, Zurich, Switzerland

News | PET Imaging | April 10, 2018
Researchers have developed a new imaging agent that could help guide and assess treatments for people with various...
Overlay Init